Cell-cycle and suppressor proteins expression in uterine cervix in HIV/ HPV co-infection: Comparative study by tissue micro-array (TMA)

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Nicol, Alcina F ^a   Pires, Andréa Rodrigues Cordovil ^b   de Souza, Simone R ^b   Nuovo, Gerard J ^c   Grinsztejn, Beatriz ^d,e   Tristão, Aparecida ^a   Russomano, Fabio B ^a   Velasque, Luciane ^d,e   E Silva, José R Lapa ^e   Pirmez, Claude ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c University Hospital   (United States)

^d Funda??o Oswaldo Cruz   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; ONCOPROTEIN; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR ELF 1; VASCULOTROPIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ELF1 PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL CYCLE REGULATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIXED INFECTION; PERSISTENT VIRUS INFECTION; PROTEIN EXPRESSION; TISSUE MICROARRAY; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WART VIRUS; CD4 LYMPHOCYTE COUNT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR;

CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HIV INFECTIONS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; PAPILLOMAVIRUS INFECTIONS; RETINOBLASTOMA PROTEIN; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55949086894     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-289     Document Type: Article

References (25)

1. Tjalma W van Waes T van den Eeden L Bogers J Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix Best practice & Research Clin Obst Gynaecol 2005, 19(4):469-483. 10.1016/j.bpobgyn.2005.02.002
2. Cho HN Kim TY Kim JW Alteration of cell cycle in cervical tumor associated with Human Papillomavirus - Cyclin-Dependent kinase inhibitors Yonsei Med J 2002, 43(6):722-728. 12497655
3. Aggarwal BB Shishodia S Sandur SK Pandey MK Sethi G Inflammation and cancer: How hot is the link? Biochem Pharmacol 2006, 72(11):1605-21. 16889756 10.1016/j.bcp.2006.06.029
4. Branca M Giorgi C Santini D Di Bonito L Ciotti M Benedetto A Paba P Costa S Bonifacio D Di Bonito P Accardi L Favalli C Syrjanen K Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or prognosis of cervical cancer J Clin Pathol 2006, 59(1):40-7. 16394279 10.1136/jcp.2005.026922
5. Huang X Brown C Ni W Maynard E Rigby AC Oetthen P Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis Blood 2006, 107(8):3153-3160. 16352813 10.1182/blood-2005-08-3206 1895750
6. Troncone G Vetrani A de Rosa G Palombini L Cyclin dependent kinase inhibitor p27 expression in normal and neoplastic cervical epithelium J Clin Pathol 1999, 52:880-887. 501653 10711250
7. Benevolo M Mottolese M Marandino F Vocaturo G Sindico R Piperno G Mariani L Sperduti I Canalini P Donnorso RP Vocaturo A Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions Mod Pathol 2006, 19(3):384-91. 16415792 10.1038/modpathol.3800551
8. Wentzensen N von Knebel Doeberitz M Biomarkers in cervical cancer screening Dis Markers 2007, 23(4):315-30. 17627065
9. Nicol AF Fernandes AT Grinsztejn B Russomano F E Silva JR Tristao A Perez M Nuovo GJ Martinez-Maza O Bonecini-Almeida M Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: Influence of HIV-1 coinfection Diagn Mol Pathol 2005, 14(1):39-47. 10.1097/ 01.pas.0000143309.81183.6c 15714063
10. Nicol AF Nuovo GJ Salomão-Estevez A Grinsztein B Tristão A Russomano F Lapa E Silva JR Oliveira MP Pirmez C Immune factors involved in the cervical immune response in the HIV/HPV co-infection J Clin Pathol 2008, 61(1):84-8. 17483251 10.1136/jcp.2007.047290
11. Gage JR Sandhu AK Nihira M Bonecini-Almeida M da G Cristoforoni P Kishimoto T Montz FJ Martínez-Maza O Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression Obstet Gynecol 2000, 96(6):879-85. 11084171 10.1016/ S0029-7844(00)01057-7
12. Nyagol J Leucci E Onnis A De Falco G Tigli C Sanseverino F Torriccelli M Palummo N Pacenti L Santopietro R Spina D Gichangi P Muchiri L Lazzi S Petraglia F Leoncini L Giordano A The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis Cancer Biol Ther 2006, 5(6):684-90. 16855377
13. Pires AR da Matta Andreiuolo F de Souza SR TMA for all: A new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles Diagn Pathol 2006, 25(1):14. 10.1186/ 1746-1596-1-14
14. Nicol AF Nuovo GJ RT in situ PCR Protocols and Applications in Methods in Microbiology Elsevier Acad Press Tor Savidge, Charalabos P 2005, 34:239-254.
15. Nicol AF Nuovo GJ Wang Y Grinsztejn B Tristao A Russomano F Perez MA Lapa e Silva JR Fernandes AT Gage JR Martinez-Maza O Bonecini-Almeida MG In situ detection of SOCS and cytokine expression in the uterine cervix from HIV/HPV coinfected women Exp Mol Pathol 2006, 81(1):42-7. 16878360 10.1016/j.yexmp.2006.01.002
16. Moberg M Gustavsson I Gyllensten U Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ Int J Cancer 2004, 112:854-859. 15386375 10.1002/ijc.20480
17. Tjalma WA Arbyan M Paavonen J van Waes TR Bogers JJ Prophylactic human papillomavirus vaccines: The beginning of the end of cervical cancer Int J Gynecol Cancer 2004, 14:751-761. 15361181 10.1111/ j.1048-891X.2004.014505.x
18. Estable MC Bell B Merzouki A Montaner JS O'Shaughnessy MV Sadowski IJ Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity J Virol 1996, 70(6):4053-62. 190286 8648743
19. Goff BA Sallin J Garcia R VanBlaricom A Paley PJ Muntz HG Evaluation of p27 in preinvasive and invasive malignancies of the cervix Gynecol Oncol 2003, 88(1):40-4. 12504625 10.1006/gyno.2002.6858
20. Shiozawa T Shiohara S Kanai M Konishi I Fujii S Nikaido T Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1) Cancer 2001, 92(12):3005-11. 11753978 10.1002/ 1097-0142(20011215)92:12<3005::AID-CNCR10153>3.0.CO;2-6
21. Clarke B Chetty R Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix Gynecol Oncol 2001, 82(2):238-46. 11531273 10.1006/gyno.2001.6306
22. Nam EJ Kim JW Kim SW Kim YT Kim JH Yoon BS Cho NH Kim S The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance Gynecol Oncol 2007, 104(1):207-11. 17046054 10.1016/j.ygyno.2006.07.043
23. Tringler B Gup CJ Singh M Groshong S Shroyer AL Heinz DA Shroyer KR Evaluation of p16INK4A and pRb expression in cervical squamous and glandular neoplasia Hum Pathol 2004, 35(6):689-696. 15188135 10.1016/ j.humpath.2004.02.012
24. Stiegler P Kasten M Giordano A The RB family of cell cycle regulatory factors J Cell Biochem Suppl 1998, 31:30-6. Review 10.1002/ (SICI)1097-4644(1998)72:30/31+<30::AID-JCB5>3.0.CO;2-J
25. De Falco G Bellan C Lazzi S Claudio P La Sala D Cinti C Tosi P Giordano A Leoncini L Interaction between HIV-1 Tat and pRb2/p130: A possible mechanism in the pathogenesis of AIDS-related neoplasms Oncogene 2003, 22(40):6214-9. 13679860 10.1038/sj.onc.1206637